Fortress Biotech, Inc. Long-term Debt, Gross
Fortress Biotech, Inc. (FBIO) had Long-term Debt, Gross of $40.00 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Debt
us-gaap:DebtInstrumentCarryingAmount · last filed 2026-08-13
- 2026-06-30: Long-term Debt, Gross $40.00M.
- 2026-03-31: Long-term Debt, Gross $40.00M.
- 2025-12-31: Long-term Debt, Gross $54.49M.
- 2021-12-31: Long-term Debt, Gross $60.45M.
| Period end | Long-term Debt, Gross |
|---|---|
| 2026-06-30 | $40.00M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $40.00M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $54.49M 10-Q · filed 2026-08-13 |
| 2021-12-31 | $60.45M 10-K · filed 2022-03-28 |
| 2021-09-30 | $60.45M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $60.00M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $60.00M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $60.00M 10-K · filed 2022-03-28 |
| 2019-12-31 | $89.74M 10-K/A · filed 2021-04-09 |
| 2012-12-31 | $1.50M 10-Q · filed 2013-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |